Center for Global Infectious Disease Research
Accelerating Progress Toward Cures
Our scientists are investigating how a baby's microbiome may offer protection from HIV. “If we can first determine the protective mechanism benefiting babies exclusively fed breast milk, we can design better prevention strategies, such as a vaccine.”
Cell Press announces one of the best reviews published in 2018 is from Alexis Kaushansky and her colleagues which describes host factors and dependencies that contribute to malaria pathogenesis during various parasite life cycle stages and their potentials for host-targeted therapies.
Learn about a unique tool and experimental workflow developed by our scientists to measure the many parameters of cell growth on single cells as they grow into colonies. Story written by CGIDR senior research scientist, Fred Mast.
Dr. Shuyi Ma shares her reaction to the news that her undergraduate mentor became the fifth woman in history to receive the Nobel Prize in Chemistry and shares how her mentor helped shaped her career.
Center for Infectious Disease Research Joins Seattle Children’s Research Institute
Developing groundbreaking treatments takes more than just the right ideas. It also takes the right people – and the CGIDR is recruiting new members.
- Scientist Reflects on Lessons Learned From Nobel Prize Winner – On the Pulse
As a female scientist studying tuberculosis (TB), Dr. Shuyi Ma was ecstatic to learn that her undergraduate mentor became the fifth woman in history to receive the Nobel Prize in Chemistry. She shares her reaction to the news and how her mentor helped shaped her career with On the Pulse.
- Center for Infectious Disease Research Joins Seattle Children's Research Institute – Seattle Children's
After 42 years as the oldest and largest, independent non-profit organization in the United States solely focused on infectious disease research, the Center for Infectious Disease Research (CIDR) will join Seattle Children's Research Institute to create a world-class team of researchers working to find viable solutions to infectious diseases that can pose risks to our communities, and disproportionately impact children and those in poverty.
- Study shows how group B strep establishes in utero infection, posing risk to baby – Newswise
Despite the substantial impact on pregnancy outcomes, scientists know little about how group B strep (GBS), a common bacteria present in the vagina of about 1 in 4 women, establishes an in utero infection. In a paper published in the Journal of Clinical Investigation, Dr. Lakshmi Rajagopal, a principal investigator in Seattle Children’s Research Institute’s Center for Global Infectious Disease Research describes a newly uncovered mechanism by which GBS gains access to a woman’s uterus.
Collaborations and partnerships are integral to the CGIDR’s approach. Our investigators work closely with colleagues at the University of Washington, Fred Hutchinson Cancer Research Center and other institutions.
Participate in Research
Help us answer questions about childhood health and illness, and help other children in the future. Learn more.